YR011 / Hangzhou Yirui Pharma - LARVOL DELTA

SAD MAD: A First-in-Human SAD and MAD Study in Healthy Participants to Evaluate Oral YR011 Tablet (clinicaltrials.gov) - P1 | N=64 | Not yet recruiting | Sponsor: Hangzhou Yirui Pharmaceutical Technology Co., Ltd | Trial completion date: Dec 2026 ➔ Dec 2027 | Initiation date: Apr 2026 ➔ Apr 2027 | Trial primary completion date: Sep 2026 ➔ Sep 2027

First-in-human • Trial completion date • Trial initiation date • Trial primary completion date

An Early-stage Clinical Trial to Evaluate the Safety, Absorption, and Disposition of YR001 Ointment Following Topical Application on the Skin of Healthy Chinese Subjects (clinicaltrials.gov) - P1 | N=18 | Recruiting | Sponsor: Hangzhou Yirui Pharmaceutical Technology Co., Ltd

New P1 trial